New search | Conferencedetail
mail
Print view
 
 

3rd In Vivo Cell Engineering and Gene Editing Summit

Evvnt Promotion / evvnt
-
09.07.2024 - 11.07.2024  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:10 PM
 
Conference themes
Welcome to the 3rd In Vivo Cell Engineering and Gene Editing Summit!

As promising pre-clinical and proof of concept results continue to emerge, the pivotal shift from the 'dream' of in vivo cell engineering and gene editing is rapidly becoming a reality as numerous companies push towards the clinic.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2291382-3?pid=4832

Speakers: Adrian Bot, Chief Scientific Officer, Capstan Therapeutics, Cecile Bauche, Chief Scientific Officer, Alaya.bio, Colin Exline, Head of Gene Editing, Primera Therapeutics, and more
 

Enquiries and Registration:

https://go.evvnt.com/2291382-2?pid=4832
Ms. Kelly Cassidy
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5097.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AMREF - African Medical and Research FoundationCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Gesellschaft für Public HealthHilfswerk AustriaEuropean Health Forum GasteinÄrzte der WeltÄrztekammer für WiennewTree